EdgarLookup

MARSH & MCLENNAN COMPANIES, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that MARSH & MCLENNAN COMPANIES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
15.4%
Profit Margin
Net income ÷ revenue
7.1%
Return on Assets
Net income ÷ assets
+10.3%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $26.98B Feb 9, 2026
FY2025 Dec 31, 2024 $24.46B Feb 9, 2026
FY2025 Dec 31, 2023 $22.74B Feb 9, 2026
FY2024 Dec 31, 2022 $20.72B Feb 10, 2025

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.16B Feb 9, 2026
FY2025 Dec 31, 2024 $4.06B Feb 9, 2026
FY2025 Dec 31, 2023 $3.76B Feb 9, 2026
FY2024 Dec 31, 2022 $3.05B Feb 10, 2025
FY2023 Dec 31, 2021 $3.14B Feb 12, 2024
FY2020 Dec 31, 2020 $374.00M Feb 17, 2021
FY2020 Sep 30, 2020 $316.00M Feb 17, 2021
FY2020 Jun 30, 2020 $572.00M Feb 17, 2021
FY2020 Mar 31, 2020 $754.00M Feb 17, 2021
FY2020 Dec 31, 2019 $391.00M Feb 17, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.22B Feb 9, 2026
FY2025 Dec 31, 2024 $5.82B Feb 9, 2026
FY2025 Dec 31, 2023 $5.28B Feb 9, 2026
FY2024 Dec 31, 2022 $4.28B Feb 10, 2025
FY2023 Dec 31, 2021 $4.31B Feb 12, 2024
FY2020 Dec 31, 2020 $571.00M Feb 17, 2021
FY2020 Sep 30, 2020 $540.00M Feb 17, 2021
FY2020 Jun 30, 2020 $885.00M Feb 17, 2021
FY2020 Mar 31, 2020 $1.07B Feb 17, 2021
FY2020 Dec 31, 2019 $592.00M Feb 17, 2021

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $58.71B Feb 9, 2026
FY2025 Dec 31, 2024 $56.48B Feb 9, 2026
FY2024 Dec 31, 2023 $48.03B Feb 10, 2025
FY2023 Dec 31, 2022 $44.11B Feb 12, 2024
FY2023 Dec 31, 2021 $44.01B Feb 12, 2024
FY2022 Dec 31, 2020 $33.05B Feb 13, 2023
FY2021 Dec 31, 2019 $31.36B Feb 16, 2022
FY2020 Dec 31, 2018 $21.58B Feb 17, 2021
FY2019 Dec 31, 2017 $20.43B Feb 20, 2020
FY2018 Dec 31, 2016 $18.19B Feb 21, 2019

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 8 Feb 9, 2026
FY2025 Dec 31, 2024 8 Feb 9, 2026
FY2025 Dec 31, 2023 7 Feb 9, 2026
FY2024 Dec 31, 2022 6 Feb 10, 2025
FY2023 Dec 31, 2021 6 Feb 12, 2024
FY2020 Dec 31, 2020 0 Feb 17, 2021
FY2020 Sep 30, 2020 0 Feb 17, 2021
FY2020 Jun 30, 2020 1 Feb 17, 2021
FY2020 Mar 31, 2020 1 Feb 17, 2021
FY2020 Dec 31, 2019 0 Feb 17, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 8 Feb 9, 2026
FY2025 Dec 31, 2024 8 Feb 9, 2026
FY2025 Dec 31, 2023 7 Feb 9, 2026
FY2024 Dec 31, 2022 6 Feb 10, 2025
FY2023 Dec 31, 2021 6 Feb 12, 2024
FY2020 Dec 31, 2020 0 Feb 17, 2021
FY2020 Sep 30, 2020 0 Feb 17, 2021
FY2020 Jun 30, 2020 1 Feb 17, 2021
FY2020 Mar 31, 2020 1 Feb 17, 2021
FY2020 Dec 31, 2019 0 Feb 17, 2021

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.69B Feb 9, 2026
FY2025 Dec 31, 2024 $2.40B Feb 9, 2026
FY2025 Dec 31, 2023 $3.36B Feb 9, 2026
FY2024 Dec 31, 2022 $1.44B Feb 10, 2025
FY2023 Dec 31, 2021 $1.75B Feb 12, 2024
FY2022 Dec 31, 2020 $2.09B Feb 13, 2023
FY2021 Dec 31, 2019 $1.16B Feb 16, 2022
FY2019 Dec 31, 2018 $1.07B Feb 20, 2020
FY2018 Dec 31, 2017 $1.21B Feb 21, 2019
FY2018 Dec 31, 2016 $1.03B Feb 21, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $19.59B Feb 9, 2026
FY2025 Dec 31, 2024 $19.95B Feb 9, 2026
FY2024 Dec 31, 2023 $13.46B Feb 10, 2025
FY2023 Dec 31, 2022 $11.50B Feb 12, 2024
FY2022 Dec 31, 2021 $10.95B Feb 13, 2023
FY2021 Dec 31, 2020 $11.31B Feb 16, 2022
FY2020 Dec 31, 2019 $11.96B Feb 17, 2021
FY2019 Dec 31, 2018 $5.82B Feb 20, 2020
FY2015 Dec 31, 2014 $3.37B Feb 24, 2016